Hypertension and dementia: Does blood pressure control favorably affect cognition?

Current Hypertension Reports

Volumn 6, Issue 5, 2004, Pages 357-362

  Majeski, Elizabeth I ^a   Widener, Colin E ^a   Basile, Jan ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ATENOLOL; CANDESARTAN; CHLORTALIDONE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PLACEBO; PROGESTERONE; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MULTIINFARCT DEMENTIA; NEUROPROTECTION; PRIMARY PREVENTION; RISK FACTOR;

EID: 5444227235     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0054-0     Document Type: Article

References (30)

1. Hebert LE, Scherr PA, Bienias JL, et al.: Alzheimer disease in the US Population: prevalence estimates using the 2000 Census. Arch Neurol 2003, 60: 1119-1122.
2. Wentzel C, MacKnight C, Hachinski V, et al.: Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam scan study. Neurology 2001, 56: 1539-1545.
3. Pohjasraara T, Yliloski MA, Kaste M, et al.: Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. Stroke 2000, 31: 2952-2957.
4. Strub R: Vascular dementia. South Med J 2003, 96: 363-366.
5. Hachinski VC, Lassen NA, Marshal J: Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974, ii: 207-210.
6. Wolfe N, Babikian VL, Knoefel JE, et al.: Frontal systems impairment following multiple lacunar infarcts. Arch Neurol 1990, 47: 129-132.
7. Shumaker SA, Legault C, Thal L, et al.: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289: 2651-2662.
8. Shumaker SA, Legault C, Kuller L, et al.: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291: 2947-2958.
9. Etminan M, Gill S, Samii A: Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies (review). BMJ 2003, 327: 128.
10. Jick H, Zornberg G, Jick S, et al.: Statins and the risk of dementia. Lancet 2000, 256: 1627-1631.
11. Engelhart MJ, Geerlings MI, Ruitenberg A, et al.: Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287: 3223-3229.
12. Morris MC, Evans DA, Bienias JL, et al.: Dietary intake of antioxidants and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002, 287: 3230-3237.
13. Sano M, Ernesto C, Thomas RG, et al.: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: The Alzheimer's Disease Cooperative Study. N Engl J Med 1997, 336: 1216-1222.
14. Verghese J, Lipton RB, Katz MJ, et al.: Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003, 348: 2508-2516.
15. Gorelick P: Stroke prevention. Arch Neurol 1995, 52: 347-354.
16. Ross GW, Petrovitch H, Masaki KH, et al.: The relation between mid-life blood pressure and dementia: the Honolulu Aging Study (abstract). Neurology 1998, 50: A229.
17. Launer LJ, Petrovich K, Foley D, et al.: The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia aging study. JAMA 1995, 274: 1846-1851.
18. Tzourio C, Ducimetiere P, Alperovitch A: Cognitive decline in individuals with high blood pressure. Neurology 1999, 53: 1948-1952.
19. Lithell H, Hansson L, Skoog I, et al.: The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003, 21: 875-886.
20. SHEP Cooperative Group: Prevention of stroke by antihypertension drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265: 3255-3264.
21. Di Bari M, Pahor M, Franse LV, et al.: Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in elderly program (SHEP) trial. Am J Epidemiol 2001, 153: 72-78.
22. Gurland B, Golden R, Challop J: Unidimensional and multi-dimensional approaches to the differential of depression and dementia in the elderly. In Alzheimer's Disease: A Report of Progress in Research. Edited by Corkin S, Davis K, Crowden J. New York: Raven Press; 1981.
23. Weissman MM, Sholomskas D, Pottenger M, et al.: Assessing depression symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1997, 106: 203-214.
24. Jette AM, Branch LG: The Framingham Disability Study: II. Physical disability among the aging. Am J Public Health 1981, 71: 1211-1216.
25. Berkman LF: The assessment of social networks and social support in the elderly. J Am Geriat Soc 1983, 31: 743-749.
26. Brayne C, Gill C, Huppert FA, et al.: Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br J Psychiatry 1995, 167: 255-262.
27. PROGRESS Collaborative Group: Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet 2001, 358: 1033-1041.
28. Tzourio C, Anderson C, Chapman N, et al.: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003, 163: 1069-1075.
29. Fagard RH, Staessen JA: Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Clin Exper Hypertens 1999, 21: 491-497.
30. Forette F, Seux ML, Staessen JA, et al.: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002, 162: 2046-2052.